Celtaxsys

#CFFact According to the #CFF Patient Registry in the US approximately 1,000 new cases of #CF are diagnosed each year.

Cystic Fibrosis is a progressive, genetic disease causing persistent lung infections and excessive lung inflammation, limiting the ability to breathe over time. #CFAwareness #CF https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/

Have you registered for Great Strides yet? #GreatStridesGA #CF

From our Heart to your Lungs, Happy Valentines Day from the #Celtaxsys team! #CF #RelationshipGoals

When children with CF had trouble pronouncing Cystic Fibrosis, a nickname with a similar ring, Sixty-Five Roses, was created. Roses have become an unofficial symbol of CF. #CF #Roses #CFFact

http://ow.ly/ZTm150kn54k

#Atlanta is not only the home for #SuperBowl LIII. It is also home for Celtaxsys. We are excited to be advancing our new medicine, once daily acebilustat, toward phase 3 development, with the goal of reducing pulmonary exacerbations for patients diagnosed with #CF.

During the Phase 2 Trial, 32% more #acebilustat treated #CF patients were free of pulmonary exacerbations as compared with placebo, when added to a patient’s CFTR standard of care.

We all know someone affected by #CF which is why Celtaxsys is passionate to focus on developing new anti-inflammatory treatments for these patients! #acebilustat #cfwarrior #cfawareness

Cold Weather with #Cystic Fibrosis means being cautious as you get out and enjoy the crisp air! http://www.cflf.org/blog/how-survive-winter-cystic-fibrosis [email protected]

A Clinical Research study in patients with #CF shows 20% reduction in pulmonary exacerbations in subjects on #acebilustat and a CFTR modulator versus modulator alone. #Pex #reductionmatters

An inspirational story about a Mom of two with Cystic Fibrosis. #CF patients and their families are a constant reminder of the importance of our work at Celtaxsys. http://ow.ly/sIOM50k5u5I Thanks @ahippiesdaughter for sharing!

Phase 2 Clinical Study Data shows #acebilustat reduced the risk in mild CF patients progressing to their first pulmonary exacerbation versus placebo. #CF